In	O
vitro	O
cytotoxic	O
potential	O
and	O
mechanism	O
of	O
action	O
of	O
selected	O
coumarins	O
,	O
using	O
human	O
renal	B-Cell
cell	I-Cell
lines	I-Cell
.	O

This	O
study	O
determined	O
the	O
selective	O
cytotoxicity	O
of	O
eight	O
coumarin	O
compounds	O
to	O
human	O
renal	B-Cell
carcinoma	I-Cell
cells	I-Cell
,	O
relative	O
to	O
non	B-Cell
-	I-Cell
carcinoma	I-Cell
proximal	I-Cell
tubular	I-Cell
cells	I-Cell
.	O

Selectivity	O
cytotoxicity	O
was	O
observed	O
following	O
exposure	O
to	O
6	O
-	O
nitro	O
-	O
7	O
-	O
hydroxycoumarin	O
(	O
6	O
-	O
NO	O
(	O
2	O
)	O
-	O
7	O
-	O
OHC	O
)	O
and	O
7	O
,	O
8	O
-	O
dihydroxycoumarin	O
(	O
7	O
,	O
8	O
-	O
OHC	O
)	O
.	O

6	O
-	O
NO	O
(	O
2	O
)	O
-	O
7	O
-	O
OHC	O
induced	O
cytotoxicity	O
was	O
irreversible	O
in	O
both	O
cell	B-Cell
lines	I-Cell
,	O
unlike	O
7	O
,	O
8	O
-	O
OHC	O
,	O
which	O
was	O
reversible	O
in	O
the	O
carcinoma	B-Cell
cells	I-Cell
only	O
.	O

Mobility	O
shift	O
and	O
BrdU	O
incorporation	O
assays	O
showed	O
that	O
both	O
compounds	O
did	O
not	O
intercalate	O
DNA	O
but	O
had	O
a	O
concentration	O
-	O
dependent	O
inhibitory	O
effect	O
on	O
its	O
synthesis	O
.	O

All	O
coumarins	O
studied	O
were	O
found	O
to	O
be	O
non	O
-	O
mutagenic	O
using	O
the	O
standard	O
Ames	O
test	O
.	O

These	O
results	O
would	O
suggest	O
that	O
6	O
-	O
NO	O
(	O
2	O
)	O
-	O
7	O
-	O
OHC	O
and	O
7	O
,	O
8	O
-	O
OHC	O
might	O
have	O
a	O
therapeutic	O
role	O
to	O
play	O
in	O
the	O
treatment	O
of	O
renal	B-Cancer
cell	I-Cancer
carcinoma	I-Cancer
.	O

